Label Changes for:
Altabax (retapamulin) ointment
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010
WARNINGS AND PRECAUTIONS
Not for Systemic or Mucosal Use subsection
- Epistaxis has been reported with the use of Altabax on nasal mucosa